SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : Full Disclosure Trading -- Ignore unavailable to you. Want to Upgrade?


To: Sam Citron who wrote (9128)7/14/2004 4:01:43 PM
From: Sam Citron  Respond to of 13403
 
RHAT SS 500 15.06



To: Sam Citron who wrote (9128)9/15/2004 4:00:35 PM
From: Sam Citron  Respond to of 13403
 
QUFCU IDEV Mar 05 7.500 Call Indevus Pharmaceuticals Incorporated Sold To Open 20 @ 1.3.

This is a covered call sale on my existing 2,000 share long position. I am also still short 10 Sep 04 7.5 puts that expire in a couple days. I don't mind if these puts are exercised as my cost basis will be $6.45 and I will have an opportunity to lower this basis even further by selling covered calls.

IDEV has been volatile to the upside lately though I haven't heard any news. Could be related to option expiration on Friday. Maybe maxpain is 7.5? At any rate, I regard the 6 month slightly out of the money call as being fairly richly valued implying a return of about 35% per annum. In this low rate environment I couldn't resist. Naturally I'll be kicking myself in March when IDEV is trading in double digits. <g>



To: Sam Citron who wrote (9128)4/5/2006 3:39:54 PM
From: Sam Citron  Respond to of 13403
 
IDEV SC 2000 $6.24 Loss of about $1,500. Saying bye to biotech. FDA processes too opaque for me.